Politics

World

Business

Entertainment

Health

GSK Acquires RAPT Therapeutics in $2.2B Deal

British pharmaceutical giant GSK Plc announces a definitive agreement to acquire US-based RAPT Therapeutics for $2.2 billion, expanding its pipeline in inflammatory and immunologic diseases.